(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride, 95.0%, 10g

Soportes de muestra ONERACK® para tubo de 16 mm, azul, 8 Unidad(es)

(3-Methyl-5-(trifluoromethyl)phenyl)boronic acid, 95.0%, 1g

D-Iditol>98.0%(HPLC)100mg

7,9-Diphenyl-8H-cyclopenta[a]acenaphthylen-8-one>95.0%(HPLC)(qNMR)5g

CIPROFLOXACIN HYDROCHLORIDE, 95%, 500mg

S-(N,N-Dimethylthiocarbamoyl)thioglycolic Acid>97.0%(T)5g

Sodium (6R,7R)-7-amino-3-(((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 97.0%, 10g

(S)-N-((3-(3-Fluoro-4-(4-(2-hydroxyacetyl)piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, 95.00%, 50mg

ULTROXA(regR) Poly(2-ethyl-2-oxazoline) Azide Terminated (n=approx. 50)500mg

(2S,4R)-4-benzamido-1-(2-((tert-butoxycarbonyl)amino)acetyl)pyrrolidine-2-carboxylic acid, 98%, 500mg

[(3-methylphenyl)(phenyl)methyl]amine hydrochloride, 95.0%, 5g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-methylpyrrolidine-2-carboxylic acid, 97.0%, 1g